Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Tandlæge Rikke Ehlers ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 0.5% 0.5%   Bankruptcy risk   2.8% 1.8% 1.5% 1.1% 0.9% 0.8% 6.3% 6.3%   Credit score (0-100)   61 73 77 84 88 89 37 37   Credit rating   BBB A A A A A BBB BBB   Credit limit (kDKK)   0.0 0.8 8.7 191.5 392.8 541.2 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   1,836 4,402 4,866 6,725 6,913 7,198 0.0 0.0   EBITDA   448 876 1,088 2,159 2,384 2,339 0.0 0.0   EBIT   348 645 798 1,833 2,024 1,903 0.0 0.0   Pre-tax profit (PTP)   229.3 366.8 584.2 1,672.4 1,899.4 1,782.0 0.0 0.0   Net earnings   173.0 270.1 457.0 1,298.5 1,531.5 1,322.8 0.0 0.0   Pre-tax profit without non-rec. items   229 367 584 1,672 1,899 1,782 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   893 3,924 4,327 4,504 5,152 5,435 0.0 0.0   Shareholders equity total   223 385 621 1,917 3,334 4,563 4,391 4,391   Interest-bearing liabilities   3,116 5,251 4,443 3,355 2,843 1,703 0.0 0.0   Balance sheet total (assets)   3,843 6,531 6,521 6,680 7,251 7,287 4,391 4,391   Net Debt   2,709 4,893 4,433 3,181 2,643 1,613 -2,854 -2,854     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   1,836 4,402 4,866 6,725 6,913 7,198 0.0 0.0   Gross profit growth   0.0% 139.8% 10.5% 38.2% 2.8% 4.1% -100.0% 0.0%   Employees   5 7 8 8 8 9 0 0   Employee growth %   0.0% 40.0% 14.3% 0.0% 0.0% 12.5% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   3,843 6,531 6,521 6,680 7,251 7,287 4,391 4,391   Balance sheet change%   0.0% 69.9% -0.1% 2.4% 8.5% 0.5% -39.7% 0.0%   Added value   448.0 876.3 1,088.4 2,159.5 2,350.4 2,339.2 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   2,860 2,693 6 -255 182 -259 -5,435 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   1.0 2.0 3.0 4.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   19.0% 14.6% 16.4% 27.3% 29.3% 26.4% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   9.1% 12.5% 12.3% 27.8% 29.1% 26.2% 0.0% 0.0%   ROI %   10.3% 13.9% 14.0% 32.9% 33.2% 28.6% 0.0% 0.0%   ROE %   77.6% 88.8% 90.9% 102.3% 58.3% 33.5% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   5.8% 5.9% 9.6% 28.8% 46.1% 62.9% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   604.7% 558.4% 407.3% 147.3% 110.9% 69.0% 0.0% 0.0%   Gearing %   1,397.2% 1,363.7% 715.6% 175.0% 85.3% 37.3% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   7.7% 6.7% 4.5% 4.2% 4.0% 5.4% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   0.7 0.4 0.1 0.2 0.2 0.4 0.0 0.0   Current Ratio   0.7 0.4 0.1 0.2 0.2 0.4 0.0 0.0   Cash and cash equivalent   406.8 358.3 9.5 174.4 200.4 89.4 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   -362.8 -1,081.7 -2,677.9 -1,971.6 -1,563.9 -534.4 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   90 125 136 270 294 260 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   90 125 136 270 298 260 0 0   EBIT / employee   70 92 100 229 253 211 0 0   Net earnings / employee   35 39 57 162 191 147 0 0